ChiCTR2300069506 版本V1.1 版本创建时间2023/06/12 19:19:04 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2300069506 

最近更新日期:

Date of Last Refreshed on:

2023-03-20 09:41:19 

注册时间:

Date of Registration:

2023-03-20 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

基于叙事医学的决策辅助模式在供精辅助生殖治疗患者中的构建及应用

Public title:

The construction and application of decision-making assistance model based on narrative medicine in patients with donor assisted reproductive therapy

注册题目简写:

English Acronym:

研究课题的正式科学名称:

基于叙事医学的决策辅助模式在供精辅助生殖治疗患者中的构建及应用

Scientific title:

The construction and application of decision-making assistance model based on narrative medicine in patients with donor assisted reproductive therapy

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

莫凤逸 

研究负责人:

莫凤逸 

Applicant:

Fengyi Mo 

Study leader:

Fengyi Mo 

申请注册联系人电话:

Applicant telephone:

13567150554

研究负责人电话:

Study leader's telephone:

13567150554

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

5612045@zju.edu.cn

研究负责人电子邮件:

Study leader's E-mail:

5612045@zju.edu.cn

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

浙江省杭州市学士路1号

研究负责人通讯地址:

浙江省杭州市学士路1号

Applicant address:

No1,Xueshi Road,Hangzhou City,Zhejiang Province

Study leader's address:

No1,Xueshi Road,Hangzhou City,Zhejiang Province

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

浙江大学医学院附属妇产科医医院

Applicant's institution:

Women‘s Hospital school of Medicine Zhejiang University

研究负责人所在单位:

浙江大学医学院附属妇产科医医院

Affiliation of the Leader:

Women‘s Hospital school of Medicine Zhejiang University

是否获伦理委员会批准:

是/Yes

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

IRB-20210328-R

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

浙江大学医学院附属妇产科医院医学伦理委员会

Name of the ethic committee:

Ethics Committee of Women's Hospital,School of Medicine,Zhejiang University

伦理委员会批准日期:

Date of approved by ethic committee:

2021-08-26 00:00:00

伦理委员会联系人:

金煜敏

Contact Name of the ethic committee:

Yumin Jin

伦理委员会联系地址:

浙江省杭州市学士路1号

Contact Address of the ethic committee:

No1,Xueshi Road,Hangzhou City,Zhejiang Province

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 571 89992355

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

浙江大学医学院附属妇产科医院

Primary sponsor:

Women‘s Hospital school of Medicine Zhejiang

研究实施负责(组长)单位地址:

浙江省杭州市学士路1号

Primary sponsor's address:

No1,Xueshi Road,Hangzhou City,Zhejiang Province

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

浙江省

市(区县):

Country:

China

Province:

Zhejiang Province

City:

单位(医院):

浙江大学医学院附属妇产科医院

具体地址:

浙江省杭州市学士路1号

Institution
hospital:

Women‘s Hospital school of Medicine Zhejiang

Address:

No1,Xueshi Road,Hangzhou City,Zhejiang Province

经费或物资来源:

浙江省卫生健康科技计划项目

Source(s) of funding:

Zhejiang Health Science and Technology Plan Project

Target disease:

male sterility

Target disease code:

研究类型:

干预性研究

Study type:

Interventional study

研究所处阶段:

I期临床试验 

Study phase:

1

研究设计:

随机平行对照 

Study design:

Parallel 

研究目的:

本项目旨在调查供精ART助孕治疗患者的治疗决策困境现状,构建一种基于叙事医学的决策辅助模式,并探讨其在供精ART助孕患者中的应用效果,对患者决策困境、焦虑抑郁情绪、决策满意度和决策后悔的影响。  

Objectives of Study:

The purpose of this project is to investigate the current situation of treatment decision-making dilemma in donor assisted reproductive patients, construct a decision-making assistance model based on narrative medicine, and explore its application effect in donor assisted reproductive patients, and its influence on patients' decision-making dilemma, anxiety and depression, decision satisfaction and decision regret.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

1.经诊断符合供精辅助生殖技术助孕治疗指征
2.夫妇双方年龄≤45周岁
3.患者具有初中及以上文化水平
4.首次接受供精辅助生殖技术助孕治疗
5.知情并自愿参加本课题研究者

Inclusion criteria

1.To meet the indications of donor assisted reproductive technology treatment
2.The age of the couple is ≤ 45 years old
3.Patients with junior high school and above education level
4.The first time to accept donor assisted reproductive technology treatment
5.Informed and volunteered to participate in the study

排除标准:

1.既往曾有辅助生殖治疗史
2.初中以下文化水平或无法独立完成问卷者
3.拒绝配合研究
4.正在参加其他临床研究的患者

Exclusion criteria:

1.Previous history of assisted reproductive treatment
2.Patients with education level below junior high school or unable to complete the questionnaire independently
3.Refused to cooperate the project
4.Patients who are participating in other clinical studies

研究实施时间:

Study execute time:

From 2023-03-20 00:00:00 To 2024-12-31 00:00:00  

征募观察对象时间:

Recruiting time:

From 2023-03-20 00:00:00 To 2024-12-31 00:00:00  

干预措施:

Interventions:

组别:

实验组

样本量:

90

Group:

Test Group

Sample size:

干预措施:

叙事医学的决策辅助模式

干预措施代码:

Intervention:

health education based on the decision support model of narrative medicine

Intervention code:

组别:

对照组

样本量:

90

Group:

Control Group

Sample size:

干预措施:

常规治疗咨询和护理教育

干预措施代码:

Intervention:

Routine treatment consultation and health education

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

浙江省 

市(区县):

 

Country:

China 

Province:

Zhejiang Province 

City:

 

单位(医院):

浙江大学医学院附属妇产科医院 

单位级别:

三级甲等 

Institution
hospital:

Women‘s Hospital school of Medicine Zhejiang

Level of the institution:

tertiary hospital

测量指标:

Outcomes:

指标中文名:

决策冲突量表

指标类型:

主要指标

Outcome:

decisional conflict scale

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

医院焦虑抑郁量表

指标类型:

主要指标

Outcome:

hospital anxiety and depression scale

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

决策后悔量表

指标类型:

主要指标

Outcome:

decision regret scale

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

决策满意度量表

指标类型:

主要指标

Outcome:

decision satisfaction scale

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

none

Tissue:

人体标本去向

使用后销毁  

说明

Fate of sample:

Destruction after use  

Note:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age years
最大 Max age 45 years

性别:

女性

Gender:

Female

随机方法(请说明由何人用什么方法产生随机序列):

采用随机数字表法

Randomization Procedure (please state who generates the random number sequence and by what method):

Grouped by random number table method

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

Blinding:

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

以文章发表的形式

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

in the form of published articles

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

将问卷编号后录入数据库,采用spss软件进行数据统计分析

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

the questionnaire was numbered and entered into the database, using SPSS to statistical analysis

数据与安全监察委员会:

Data and Safety Monitoring Committee:

暂未确定/Not yet

注册人:

Name of Registration:

 2023-03-20 09:40:50